Andrew N Schiff's Net Worth

$351 Million

Estimate Recalculated Feb 20, 2024 05:10PM EST

Who is Andrew N Schiff?

Andrew N Schiff has an estimated net worth of $351 Million. This is based on reported shares across multiple companies, which include Zeltiq Aesthetics Inc, CEMPRA, INC., Aclaris Therapeutics, Inc., Monte Rosa Therapeutics, Inc., ViewRay, Inc., Zosano Pharma Corp, Esperion Therapeutics, Inc., ADMA BIOLOGICS, INC., Loxo Oncology, Inc., AGILE THERAPEUTICS INC, Elevation Oncology, Inc., Syros Pharmaceuticals, Inc., Cidara Therapeutics, Inc., T2 Biosystems, Inc., TRANSENTERIX INC., SUNESIS PHARMACEUTICALS INC, Durata Therapeutics, Inc., Versartis, Inc., MYOGEN INC, Sirion Holdings, Inc., Adams Respiratory Therapeutics, Inc., BARRIER THERAPEUTICS INC, INTERPHARM HOLDINGS INC, and PLANET TECHNOLOGIES, INC.

SEC CIK

Andrew N Schiff's CIK is 0001172252

Past Insider Trading and Trends

2014 was Andrew N Schiff's most active year for acquiring shares with 21 total transactions. Andrew N Schiff's most active month to acquire stocks was the month of May. 2014 was Andrew N Schiff's most active year for disposing of shares, totalling 16 transactions. Andrew N Schiff's most active month to dispose stocks was the month of October. 2011 saw Andrew N Schiff paying a total of $10,000,003.00 for 769,231 shares, this is the most they've acquired in one year. In 2018 Andrew N Schiff cashed out on 1,400,000 shares for a total of $251,202,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Zeltiq Aesthetics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.61M
0
Apr 28
Form 4
-23.84%
-500.00K
$36.39
-$18,195,038.45
1.6M
Aug 11
Form 4
+89.35%
6.2K
13.14K
Jun 16
Form 4
0
$30.13
-$987,791.85
6.94K
Scheduled
Dec 7 - Dec 8
Form 4
-10.88%
-255.99K
$30.73
-$7,867,821.85
2.1M
Nov 20 - Nov 23
Form 4
-9.39%
-244.01K
$30.77
-$7,507,946.37
2.35M
Nov 18 - Nov 19
Form 4
+12.85%
790
6.94K
Jul 22
Form 4
+433.68%
5K
6.15K
Jun 17
Form 4
0
$22.55
-$792,970.75
1.15K
Scheduled
Sep 2
Form 4
0
0
May 30
Form 4
-27.55%
-990.77K
2.61M
Jan 23
Form 4
-13.78%
-575.00K
$12.22
-$7,026,500.00
3.6M
Nov 14
Form 4
0
0
Jun 19
Form 4
0
0
Jun 14
Form 4
+22.60%
769.23K
$13.00
$10,000,003.00
4.17M
Oct 24
Form 3
0
0
No matching records found

CEMPRA, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+58.37%
1.21M
$6.00
$7,281,978.00
3.29M
Feb 7
Form 3/A
0
0
No matching records found

Aclaris Therapeutics, Inc. (ACRS) Snapshot price: $1.1398

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
4.51K
4.51K
Jun 1 - Jun 2
Form 4
-11.04%
-53.93K
$17.05
-$919,589.25
434.45K
Scheduled
Nov 10 - Nov 14
Form 4
-7.78%
-41.17K
$17.01
-$700,355.02
488.38K
Scheduled
Oct 24 - Oct 26
Form 4
-8.95%
-52.04K
$16.57
-$862,109.13
529.55K
Scheduled
Oct 17 - Oct 18
Form 4
-1.24%
-7.32K
$16.16
-$118,349.25
581.59K
Scheduled
Oct 7
Form 4
-7.18%
-45.54K
$16.45
-$749,002.06
588.92K
Scheduled
Oct 4 - Oct 6
Form 4
-100.00%
-19.57K
$15.14
-$296,268.88
0
Scheduled
Jun 17
Form 4
+20.70%
3.36K
19.57K
Jun 2 - Jun 3
Form 4
0
0
Jun 3
Form 4
+82.62%
7.33K
16.21K
Jun 4 - Jun 6
Form 4
8.88K
8.88K
Mar 2
Form 4
0
0
Jun 6
Form 4
0
0
Jun 7
Form 4
+20.65%
108.6K
$23.02
$2,499,995.02
634.46K
Aug 16
Form 4
0
0
Aug 9
Form 3
0
0
No matching records found

Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $5.07

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 14
Form 4
0
0
Jun 15
Form 4
0
0
Jun 23
Form 3
0
0
No matching records found

ViewRay, Inc. (VRAYQ) Snapshot price: $0.000001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found